Current status of sentinel lymph node biopsy in solid malignancies

被引：15

作者：

Goyal A. ^{[1
]}

Mansel R.E. ^{[1
]}

机构：

[1] Department of Surgery, University of Wales, College of Medicine, Cardiff

来源：

World Journal of Surgical Oncology | / 2卷 / 1期

关键词：

Breast cancer; Colon cancer; Lymphatic mapping; Melanoma; Randomised trials; Sentinel node biopsy;

D O I：

10.1186/1477-7819-2-9

中图分类号：

学科分类号：

摘要：

Lymphatic mapping and sentinel lymph node biopsy were first reported in 1977 by Cabanas for penile cancer. Since that time, the technique has become rapidly assimilated into clinical practice. The sentinel node concept has been validated in cutaneous melanoma and breast cancer. However, follow-up data of patients from randomised trials is needed to establish the clinical significance of sentinel lymph node biopsy before accepting the procedure as a standard of care. This technique has the potential to be utilised in all solid tumours like colon, gastric, oesophageal, lung, gynaecologic, and head and neck cancer. This paper reviews the current status of sentinel lymph node biopsy in solid tumours. © 2004 Goyal and Mansel; licensee BioMed Central Ltd.

引用

页数：7

共 49 条

[1]

Cabanas R.M., An approach for the treatment of penile carcinoma, Cancer, 39, pp. 456-466, (1977)

[2]

Morton D.L., Wen D.R., Wong J.H., Economou J.S., Cagle L.A., Storm F.K., Foshag L.J., Cochran A.J., Technical details of intraoperative lymphatic mapping for early stage melanoma, Arch. Surg., 127, pp. 392-399, (1992)

[3]

Alex J.C., Krag D.N., Gamma-probe guided localization of lymph nodes, Surg. Oncol., 2, pp. 137-143, (1993)

[4]

Balch C.M., Soong S.J., Bartolucci A.A., Urist M.M., Karakousis C.P., Smith T.J., Temple W.J., Ross M.I., Jewell W.R., Mihm M.C., Barnhill R.L., Wanebo H.J., Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger, Ann. Surg., 224, pp. 255-263, (1996)

[5]

Sim F.H., Taylor W.F., Ivins J.C., Pritchard D.J., Soule E.H., A prospective randomised study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results, Cancer, 41, pp. 948-956, (1978)

[6]

Veronesi U., Adamus J., Bandiera D.C., Brennhovd I.O., Caceres E., Cascinelli N., Claudio F., Ikonopisov R.L., Javorskj V.V., Kirov S., Kulakowski A., Lacoub J., Lejeune F., Mechl Z., Morabito A., Rode I., Sergeev S., van Slooten E., Szcygiel K., Trapeznikov N.N., Inefficacy of immediate node dissection in stage 1 melanoma of the limbs, N. Engl. J. Med., 297, pp. 627-630, (1977)

[7]

Uren R.F., Howman-Giles R., Thompson J.F., Shaw H.M., Quinn M.J., O'Brien C.J., McCarthy W.H., Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma, Melanoma Res., 4, pp. 395-399, (1994)

[8]

Godellas C.V., Berman C.G., Lyman G., Cruse C.W., Rapaport D., Heller R., Wang X., Glass F., Fenske N., Messina J., The identification and mapping of melanoma regional nodal metastases: Minimally invasive surgery for the diagnosis of nodal metastases, Am. Surg., 61, pp. 97-101, (1995)

[9]

Kamath D., Rapaport D., DeConti R., Cruse C.W., Wells K., Glass F., Messina J., Fenske N., Brobeil A., Berman C., Puleo C., Reintgen D., Redefining cutaneous lymphatic flow: The necessity of preoperative lymphoscintigraphy in the management of malignant melanoma, J. Fla. Med. Assoc., 84, pp. 182-187, (1997)

[10]

Uren R.F., Howman-Giles R.B., Shaw H.M., Thompson J.F., McCarthy W.H., Lymphoscintigraphy in high-risk melanoma of the trunk: Predicting draining node groups, defining lymphatic channels and locating the sentinel node, J. Nucl. Med., 34, pp. 1435-1440, (1993)

← 1 2 3 4 5 →